Home/ Stocks/ AXSM

Axsome Therapeutics, Inc

AXSM XNAS

$212.74 +2.61 (+1.24%) ▲ 15-min delayed

Open

$210.13

High

$214.39

Low

$208.61

Volume

1.02M

Market Cap

$10.81B

About Axsome Therapeutics, Inc

Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 925 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q1 2026	$191.20M	$-64,542,000	$-1.26
FY 2025	$638.50M	$-183,174,000	$-3.68
Q3 2025	$170.99M	$-47,229,000	$-0.94
Q2 2025	$150.04M	$-47,973,000	$-0.97

Earnings & Analyst Ratings

Next Earnings: Mon, Nov 2, 2026

Calendar →

Related Market News

No specific coverage for AXSM yet. Check out our latest market news or earnings calendar.

Get AXSM Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Axsome Therapeutics, Inc.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.